Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.57)
# 865
Out of 5,090 analysts
503
Total ratings
42.12%
Success rate
8.03%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Buy | $26 → $39 | $33.32 | +17.05% | 3 | Dec 5, 2025 | |
| BLTE Belite Bio | Maintains: Buy | $98 → $185 | $150.00 | +23.33% | 22 | Dec 1, 2025 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $19 | $12.58 | +51.03% | 29 | Nov 25, 2025 | |
| BLFS BioLife Solutions | Reiterates: Buy | $32 | $25.46 | +25.69% | 4 | Nov 24, 2025 | |
| BNGO Bionano Genomics | Maintains: Buy | $11 → $7 | $1.68 | +316.67% | 3 | Nov 24, 2025 | |
| DRTS Alpha Tau Medical | Reiterates: Buy | $9 | $3.89 | +131.36% | 21 | Nov 24, 2025 | |
| CODX Co-Diagnostics | Reiterates: Neutral | n/a | $0.37 | - | 24 | Nov 24, 2025 | |
| LFMD LifeMD | Maintains: Buy | $13 → $9 | $3.50 | +157.14% | 11 | Nov 19, 2025 | |
| VNRX VolitionRx | Maintains: Buy | $2.5 → $1.5 | $0.30 | +400.50% | 4 | Nov 17, 2025 | |
| VVOS Vivos Therapeutics | Initiates: Buy | $7 | $2.07 | +238.16% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.72 | +454.55% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $36 | $21.69 | +65.98% | 6 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $3.15 | +122.22% | 5 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $69 | $45.75 | +50.82% | 7 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $21.68 | +93.73% | 17 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $89 | $76.66 | +16.10% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.76 | +184.09% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $17 | $16.82 | +1.07% | 20 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $2.5 | $0.69 | +264.22% | 23 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $13.16 | +158.36% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.90 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.91 | +266.49% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.79 | +46.14% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $4.40 | +127.27% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.03 | +392.61% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.40 | +185.71% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.58 | +469.62% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.90 | +105.13% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $17.74 | +29.65% | 23 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.89 | - | 24 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.06 | +277.36% | 7 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $13.47 | +18.78% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $16.40 | +9.76% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $18.53 | +34.92% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $8.94 | +336.24% | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.34 | +123.88% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.63 | +376.49% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.49 | +1,104.82% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.16 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $3.36 | +14,780.95% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.13 | +8,361.54% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $11.25 | +326.67% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $105.63 | -82.01% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.88 | - | 2 | Apr 16, 2020 |
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $26 → $39
Current: $33.32
Upside: +17.05%
Belite Bio
Dec 1, 2025
Maintains: Buy
Price Target: $98 → $185
Current: $150.00
Upside: +23.33%
Ocular Therapeutix
Nov 25, 2025
Reiterates: Buy
Price Target: $19
Current: $12.58
Upside: +51.03%
BioLife Solutions
Nov 24, 2025
Reiterates: Buy
Price Target: $32
Current: $25.46
Upside: +25.69%
Bionano Genomics
Nov 24, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $1.68
Upside: +316.67%
Alpha Tau Medical
Nov 24, 2025
Reiterates: Buy
Price Target: $9
Current: $3.89
Upside: +131.36%
Co-Diagnostics
Nov 24, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.37
Upside: -
LifeMD
Nov 19, 2025
Maintains: Buy
Price Target: $13 → $9
Current: $3.50
Upside: +157.14%
VolitionRx
Nov 17, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.30
Upside: +400.50%
Vivos Therapeutics
Nov 17, 2025
Initiates: Buy
Price Target: $7
Current: $2.07
Upside: +238.16%
Nov 17, 2025
Maintains: Buy
Price Target: $3 → $4
Current: $0.72
Upside: +454.55%
Nov 14, 2025
Maintains: Buy
Price Target: $54 → $36
Current: $21.69
Upside: +65.98%
Nov 13, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.15
Upside: +122.22%
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $69
Current: $45.75
Upside: +50.82%
Nov 11, 2025
Maintains: Buy
Price Target: $36 → $42
Current: $21.68
Upside: +93.73%
Nov 7, 2025
Maintains: Buy
Price Target: $98 → $89
Current: $76.66
Upside: +16.10%
Nov 3, 2025
Reiterates: Buy
Price Target: $5
Current: $1.76
Upside: +184.09%
Oct 31, 2025
Maintains: Buy
Price Target: $16 → $17
Current: $16.82
Upside: +1.07%
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.69
Upside: +264.22%
Oct 7, 2025
Reiterates: Buy
Price Target: $34
Current: $13.16
Upside: +158.36%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.90
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $1.91
Upside: +266.49%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $4.79
Upside: +46.14%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.40
Upside: +127.27%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.03
Upside: +392.61%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.40
Upside: +185.71%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $1.58
Upside: +469.62%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $3.90
Upside: +105.13%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $17.74
Upside: +29.65%
Aug 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.89
Upside: -
Jul 29, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.06
Upside: +277.36%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $13.47
Upside: +18.78%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $16.40
Upside: +9.76%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $18.53
Upside: +34.92%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $8.94
Upside: +336.24%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.34
Upside: +123.88%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.63
Upside: +376.49%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.49
Upside: +1,104.82%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.16
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $3.36
Upside: +14,780.95%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.13
Upside: +8,361.54%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $11.25
Upside: +326.67%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $105.63
Upside: -82.01%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.88
Upside: -